Outset Medical, Inc. (OM)
About Outset Medical, Inc.
Outset Medical Inc is a medical technology company pioneering a technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.
This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.
Financial summary
- Revenue FY2025
- $119.5M
- Net income
- -$81.7M
- Total assets
- $264.5M
- Market cap
- $74.9M
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $74.9M
- Shares outstanding
- 18.3M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Sep 15, 2020
Outset Medical, Inc. (OM) Stock Price
- Reported a net loss of $81.7M in FY2025.
- Trading 74% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Outset Medical, Inc..
Write a review
News about Outset Medical, Inc.
News & sentiment via Polygon.io
Outset Medical, Inc.: frequently asked questions
Is Outset Medical, Inc. an American company?
Outset Medical, Inc. is a US-based company headquartered in San Jose, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Outset Medical, Inc. headquartered?
Outset Medical, Inc. is headquartered in San Jose, California, United States.
Is Outset Medical, Inc. publicly traded?
Yes — Outset Medical, Inc. is a publicly traded company. Its stock trades under the ticker symbol OM on the NASDAQ.
What does Outset Medical, Inc. do?
Outset Medical, Inc. is an American Medical Devices company in the Health & Beauty sector.
